Supplementary Table S1 from Modernizing Clinical Trial Eligibility Criteria: Recommendations of the ASCO-Friends of Cancer Research Laboratory Reference Ranges and Testing Intervals Work Group

MLA

David E. Gerber, et al. Supplementary Table S1 from Modernizing Clinical Trial Eligibility Criteria: Recommendations of the ASCO-Friends of Cancer Research Laboratory Reference Ranges and Testing Intervals Work Group. Mar. 2023. EBSCOhost, https://doi.org/10.1158/1078-0432.22484393.v1.

APA

David E. Gerber, Brandon A. Mahal, Abhilasha Nair, Lee Jones, Michael A. Thompson, Laura S. Wood, Nicole Richie, Anitra Fielding, Elaine Chang, Suzanne Jones, Mark D. Stewart, & Alexander I. Spira. (2023). Supplementary Table S1 from Modernizing Clinical Trial Eligibility Criteria: Recommendations of the ASCO-Friends of Cancer Research Laboratory Reference Ranges and Testing Intervals Work Group. https://doi.org/10.1158/1078-0432.22484393.v1

Chicago

David E. Gerber, Brandon A. Mahal, Abhilasha Nair, Lee Jones, Michael A. Thompson, Laura S. Wood, Nicole Richie, et al. 2023. “Supplementary Table S1 from Modernizing Clinical Trial Eligibility Criteria: Recommendations of the ASCO-Friends of Cancer Research Laboratory Reference Ranges and Testing Intervals Work Group,” March. doi:10.1158/1078-0432.22484393.v1.